Clinical and economic impact of etanercept in real-life:a prospective, non-interventional study of etanercept in the treatment of patients with moderate to severe plaque psoriasis in private dermatologist settings (ESTHER)

Autor: Henrik F Lorentzen, Claus Zachariae, Christian Grønhøj Larsen, Theis Huldt-Nystrøm, Lars Kåre Dotterud, Rose-Marie Lindkvist, Peter Hundevadt Andersen, Susanne Qvitzau

Publikováno v: Larsen, C G, Andersen, P H, Lorentzen, H, Zachariae, C, Huldt-Nystrøm, T, Dotterud, L K, Lindkvist, R-M & Qvitzau, S 2013, ' Clinical and economic impact of etanercept in real-life : a prospective, non-interventional study of etanercept in the treatment of patients with moderate to severe plaque psoriasis in private dermatologist settings (ESTHER) ', European Journal of Dermatology, vol. 23, no. 6, pp. 774-81 . https://doi.org/10.1684/ejd.2013.2173

BACKGROUND: Real-life data on the therapeutic effectiveness and costs of etanercept are scarce.OBJECTIVES: To assess the clinical and economic impact of etanercept in patients with psoriasis in Denmark and Norway.MATERIAL & METHODS: This prospective,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d859fcd13fbb8868957eb391c27230bf
https://pure.au.dk/portal/da/publications/clinical-and-economic-impact-of-etanercept-in-reallife(1d502766-9e45-4364-a592-4a7ce2bb0cd7).html